As a result, S100 proteins function as key endogenous amplifiers of neuroimmune activity and as emerging biomarkers of CNS pathology, offering significant potential as targets for therapeutic intervention in numerous neuroinflammatory and neurodegenerative diseases. Here, S100A1 is linked to neurodegenerative disease.